Cargando…
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
BACKGROUND: This study evaluated the efficacy and safety of docetaxel combined with lobaplatin, relative to docetaxel combined with gemcitabine, for treating patients with recurrent metastatic breast cancer (rMBC). METHODS: Patients with rMBC received ≥2 cycles (21 days each) of either docetaxel and...
Autores principales: | Li, Fenghu, Wang, Bi, He, Mingyuan, Chang, Jianying, Li, Jiehui, Shan, Lang, Wang, Heran, Hong, Wei, Luo, Daiqin, Song, Yang, Liu, Liyang, Li, Huiqin, Ran, Li, Chen, Tengxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946339/ https://www.ncbi.nlm.nih.gov/pubmed/31876741 http://dx.doi.org/10.1097/MD.0000000000018513 |
Ejemplares similares
-
Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review
por: Chen, Wei-xun, et al.
Publicado: (2019) -
Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis
por: Luo, Fang, et al.
Publicado: (2021) -
Machine-learning-based analysis of the sensitivity and specificity on lipid-lowering effect of one-month-administered statins
por: Liu, Huiqin, et al.
Publicado: (2023) -
Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review
por: Gu, Wei-Jun, et al.
Publicado: (2017) -
Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article
por: Zeng, Xiang Xia, et al.
Publicado: (2018)